DE69637770D1 - Verfahren zur herstellung von amidderivaten und ihren zwischenverbindungen - Google Patents

Verfahren zur herstellung von amidderivaten und ihren zwischenverbindungen

Info

Publication number
DE69637770D1
DE69637770D1 DE69637770T DE69637770T DE69637770D1 DE 69637770 D1 DE69637770 D1 DE 69637770D1 DE 69637770 T DE69637770 T DE 69637770T DE 69637770 T DE69637770 T DE 69637770T DE 69637770 D1 DE69637770 D1 DE 69637770D1
Authority
DE
Germany
Prior art keywords
compounds
producing
intermediate compounds
preparation
xvi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69637770T
Other languages
English (en)
Inventor
Takashi Inaba
Yasuki Yamada
James Shanley
Michael Deason
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tobacco Inc
Agouron Pharmaceuticals LLC
Original Assignee
Japan Tobacco Inc
Agouron Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc, Agouron Pharmaceuticals LLC filed Critical Japan Tobacco Inc
Application granted granted Critical
Publication of DE69637770D1 publication Critical patent/DE69637770D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/04—Seven-membered rings not condensed with other rings
    • C07D321/06—1,3-Dioxepines; Hydrogenated 1,3-dioxepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE69637770T 1995-09-26 1996-09-24 Verfahren zur herstellung von amidderivaten und ihren zwischenverbindungen Expired - Fee Related DE69637770D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24818495 1995-09-26
PCT/JP1996/002757 WO1997011938A1 (fr) 1995-09-26 1996-09-24 Procede de production de derives amides et de leurs intermediaires

Publications (1)

Publication Number Publication Date
DE69637770D1 true DE69637770D1 (de) 2009-01-15

Family

ID=17174459

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69637770T Expired - Fee Related DE69637770D1 (de) 1995-09-26 1996-09-24 Verfahren zur herstellung von amidderivaten und ihren zwischenverbindungen

Country Status (10)

Country Link
US (1) US6121468A (de)
EP (1) EP0984000B1 (de)
JP (1) JP3611332B2 (de)
AT (1) ATE416158T1 (de)
AU (1) AU717710B2 (de)
DE (1) DE69637770D1 (de)
DK (1) DK0984000T3 (de)
ES (1) ES2318852T3 (de)
PT (1) PT984000E (de)
WO (1) WO1997011938A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2259927A1 (en) 1996-07-12 1998-01-22 Leukosite, Inc. Chemokine receptor antagonists and methods of use therefor
US5962725A (en) 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
UA67727C2 (uk) * 1996-09-05 2004-07-15 Агурон Фармасевтікелс, Інк. Проміжні сполуки для одержання інгібіторів віл-протеази і способи одержання інгібіторів віл-протеази
US5925759A (en) 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
WO1998045271A1 (en) * 1997-04-10 1998-10-15 F. Hoffman-La Roche Ag Process for making a butylthio-isoquinoline and intermediates therefor
US6130348A (en) 1997-04-10 2000-10-10 Hoffmann-La Roche Inc. Process for a phenylthiobutyl-isoquinoline and intermediates therefor
US6084107A (en) * 1997-09-05 2000-07-04 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
IN188157B (de) 1998-01-16 2002-08-24 Japan Tobacco Inc
AU6852998A (en) * 1998-04-16 1999-11-08 Nagase & Company, Ltd. Process for preparing chloro alcohol derivatives and intermediates
US6403799B1 (en) 1999-10-21 2002-06-11 Agouron Pharmaceuticals, Inc. Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors
JP2004115510A (ja) * 2002-09-05 2004-04-15 Toray Fine Chemicals Co Ltd ピペラジン誘導体の製造方法
SG145573A1 (en) * 2003-05-08 2008-09-29 Pfizer Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
US20070192711A1 (en) * 2006-02-13 2007-08-16 Research In Motion Limited Method and arrangement for providing a primary actions menu on a handheld communication device
WO2006021964A2 (en) * 2004-08-23 2006-03-02 Matrix Laboratories Ltd Novel crystalline forms of nelfinavir mesylate
US20110046199A1 (en) * 2008-01-17 2011-02-24 Purdue Research Foundation Small molecule inhibitors of hiv proteases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56127373A (en) * 1980-01-31 1981-10-06 Univ California Novel amino-dioxepane intermediate for synthesizing novel nonionic contrast agent
US4341756A (en) * 1980-01-31 1982-07-27 The Regents Of The University Of California Novel amino-dioxepane intermediates for the synthesis of new non-ionic contrast media
DE3150917A1 (de) * 1981-12-18 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen "2-amino-1-(1,3-dioxolan-4-yl)-ethanol-verbindungen, deren herstellung und verwendung zur weiterverarbeitung"
US5733906A (en) * 1993-10-12 1998-03-31 Eli Lilly And Company Inhibitors of HIV Protease useful for the treatment of Aids
MX9308016A (es) * 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
DE69504220T2 (de) * 1994-02-21 1999-04-29 Pliva Pharm & Chem Works Sulfonamidodioxepane mit hypoglykämischen Eigenschaften, Methoden zu ihrer Herstellung, ihre Zwischenprodukte und Salze

Also Published As

Publication number Publication date
US6121468A (en) 2000-09-19
ATE416158T1 (de) 2008-12-15
DK0984000T3 (da) 2009-04-06
JP3611332B2 (ja) 2005-01-19
EP0984000A4 (de) 2004-08-11
ES2318852T3 (es) 2009-05-01
EP0984000A1 (de) 2000-03-08
PT984000E (pt) 2009-02-06
EP0984000B1 (de) 2008-12-03
AU7002196A (en) 1997-04-17
AU717710B2 (en) 2000-03-30
WO1997011938A1 (fr) 1997-04-03

Similar Documents

Publication Publication Date Title
DE69637770D1 (de) Verfahren zur herstellung von amidderivaten und ihren zwischenverbindungen
AU2001252595A1 (en) Process for producing optically active sulfoxide derivative
FI933566A (fi) Nytt foerfarande foer framstaellning av 7-(substituerade)-9-((substituerad glycyl)amido)-6-demetyl-6-deoxitetracykliner
DE69327567T2 (de) Verfahren zur Herstellung von Alanylglutamin
ATE288891T1 (de) Verfahren zur herstellung von amid-derivaten und ihren zwischenverbindungen
DE69231815D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
DE69513657D1 (de) Verfahren zur Herstellung von 1-substituierten 2-Cyanoimidazolen
DE69521012T2 (de) Verfahren zur Herstellung von 1-(4,5-Dihydro)2-thiazolyl-3-Azetidinthiolderivaten
ATE175967T1 (de) Verfahren zur herstellung von 2-amino-6- halogenopurin und synthese einer zwischenverbindung
ATE126510T1 (de) Herstellung von isochinolinderivaten.
DE60039533D1 (de) Verbessertes verfahren zur herstellung von 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamid hydrochlorid und anderen derivaten von 2-hydroxy-1,3-diamin
DE69127960T2 (de) Verfahren zur Herstellung von (S)-vinyl- und (S)-allenyl-Gaba
ATE226570T1 (de) Verfahren zur herstellung von halogenacetamidderivaten
ATE104959T1 (de) Verfahren zur herstellung von vitamin a aldehyd.
DE60144570D1 (de) Verfahren zur herstellung von optisch aktiven sulfonamiden und zwischenprodukte zur deren synthese
ATE160147T1 (de) Verfahren zur herstellung von enantiomer reinem imidazo (4,5,1-jk) (1,4)-benzodiazepin-2(1h)- thionen
ATE151428T1 (de) Verfahren zur herstellung von 3- exomethylencephamsulfoxydderivate und zwischenverbindungen
DK0756593T3 (da) Fremgangsmåde til fremstilling af 2-piperazincarboxylsyrederivater
ATE142637T1 (de) Neues verfahren zur herstellung von 20-oxo, 17- alpha, 21-dihydroxy derivaten von pregnan und neue zwischenprodukte dafür
DE69108587D1 (de) Verfahren und Zwischenprodukte zur Herstellung von optisch aktiven Chromanderivaten.

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: INABA, TAKASHI, TAKATSUKI-SHI, OSAKA, JP

Inventor name: YAMADA, YASUKI, TAKATSUKI-SHI, OSAKA 569-11, JP

Inventor name: SHANLEY, JAMES, SAN DIEGO, CA 92117, US

Inventor name: DEASON, MICHAEL, POWAY, CA 92064, US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee